Angina Pectoris
📧 Sign up to get email alerts when something new happens for Angina Pectoris.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-04-30FDA Approved: NITROGLYCERIN — Original Application (Natco Pharma USA LLC)
FDA has approved Natco Pharma USA LLC's Nitroglycerin generic under an Original Application (ANDA211604).
-
FDA approval · 2019-04-29FDA Approved: FELODIPINE — Original Application (Carlsbad Technology, Inc.)
FDA approved Felodipine through an original application filed by Carlsbad Technology, Inc., for treatment of hypertension. Felodipine is als…
-
FDA approval · 2019-03-22FDA Approved: PROPRANOLOL HYDROCHLORIDE — Supplemental Application (Breckenridge Pharmaceutical, Inc.)
The FDA approved Breckenridge Pharmaceutical's supplemental application for propranolol hydrochloride (generic propranolol HCl).
-
FDA approval · 2019-03-12FDA Approved: NIFEDIPINE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approves Ingenus Pharmaceuticals' generic nifedipine under an Original Application (ANDA210614). The approved product is indicated for h…
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE Xpedition SV Japan PMS)
Clinical trial update for XIENCE Xpedition Everolimus-Eluting Coronary Stent in Japan; completed post-marketing surveillance with posted res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2019-01-31Clinical Trial Update: A Registry to Evaluate Patterns of Care Associated With the Use of Corus CAD (or ASGES) in Primary Care Settings
A completed registry update assessing how CardioDx's Corus CAD (ASGES) is used in primary care to evaluate patterns of care for suspected co…
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Clinical Utility of an Age, Sex, and Gene Expression Score (ASGES or Corus CAD) in African American Patients.
Clinical update on the utility of the ASGES (Corus CAD) gene-expression score in African American patients with suspected coronary artery di…
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Personalized Risk Evaluation and Diagnosis (Using Corus CAD or ASGES) in the Coronary Tree
Completed clinical trial evaluating personalized risk assessment and diagnosis for coronary disease using Corus CAD or ASGES.
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Utility of a Molecular Personalized Coronary Gene Expression Test (Corus CAD or ASGES) on Cardiology Practice Pattern
A completed clinical trial evaluated whether the Corus CAD gene-expression test (ASGES) influences cardiology practice patterns in patients …
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Understanding the Effect of Metformin on Corus CAD (or ASGES)
A completed clinical trial evaluating the effect of metformin on Corus CAD/ASGES, a coronary disease assessment tool.
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Effect of Exercise Stress Testing on Peripheral Gene Expression Using Corus CAD (or ASGES) Diagnostic Test
Completed clinical trial evaluating the impact of exercise stress testing on peripheral gene expression as measured by the Corus CAD (ASGES)…
-
CLINICAL_TRIALS withdrawal · 2019-01-31Clinical Trial Update: Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
A clinical trial evaluating the use of the Corus CAD (ASGES) diagnostic test in primary care decision making has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Coronary Obstruction Detection by Molecular Personalized Gene Expression (Corus CAD or ASGES)
A completed clinical trial update evaluating Corus CAD (ASGES), a gene-expression test for detecting obstructive coronary artery disease in …
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Investigation of a Novel Gene Expression Test (ASGES or Corus CAD) for Diagnosis of Obstructive Coronary Artery Disease
Clinical trial update indicating the study evaluating the gene expression test ASGES (Corus CAD) for diagnosing obstructive coronary artery …
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: Absorb GT1 Japan PMS [NA]
This clinical trial update reports completion and posted results of the Absorb GT1 Japan post-market surveillance study evaluating the stent…
-
FDA approval · 2018-12-28FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Armas Pharmaceuticals Inc.)
FDA approves Armas Pharmaceuticals' verapamil hydrochloride as an original ANDA generic; standard indications for verapamil HCl include hype…
-
EMA withdrawal · 2018-12-20EMA Withdrawn: Ivabradine JensonR (ivabradine hydrochloride) — JensonR+ Limited
The EMA has withdrawn Ivabradine JensonR (ivabradine hydrochloride) from the market under the MAH JensonR+ Limited, effective as of 11/11/20…
-
FDA approval · 2018-12-19FDA Approved: METOPROLOL SUCCINATE — Original Application (Oryza Pharmaceuticals, Inc)
The FDA approved Oryza Pharmaceuticals' generic metoprolol succinate product, an extended-release beta-blocker used to treat hypertension, a…
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Absorption and Pharmacokinetics of Nitroglycerin to a New Formulation [Phase 4]
Phase 4 clinical trial update examining absorption and pharmacokinetics of a new nitroglycerin formulation for angina pectoris.
-
CLINICAL_TRIALS trial_result · 2018-11-30Clinical Trial Update: Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management [Phase 4]
Phase 4 trial comparing ticagrelor with clopidogrel in Asian/Korean patients with acute coronary syndromes undergoing invasive management; c…
-
FDA approval · 2018-11-05FDA Approved: ISOSORBIDE MONONITRATE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approved Ingenus Pharmaceuticals, LLC's original application for isosorbide mononitrate, a generic product indicated for the prevention …
-
FDA approval · 2018-10-29FDA Approved: METOPROLOL SUCCINATE — Supplemental Application (Zydus Pharmaceuticals (USA) Inc.)
The FDA approved a supplemental application for metoprolol succinate submitted by Zydus Pharmaceuticals (USA) Inc., updating the labeling fo…
-
FDA approval · 2018-10-26FDA Approved: METOPROLOL SUCCINATE — Original Application (BluePoint Laboratories)
FDA approved a generic metoprolol succinate product from BluePoint Laboratories under an original ANDA for the treatment of hypertension, an…
-
FDA approval · 2018-10-26FDA Approved: FELODIPINE — Original Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals' felodipine extended-release tablets under an original generic application (ANDA). The product is a…
-
CLINICAL_TRIALS trial_result · 2018-09-18Clinical Trial Update: Lesional Evaluation of High Risk Patients With Neoatherosclerosis Treated With Rosuvastatin and Eicosapentaenoic Acid Using Optical Coherence Tomography(OCT)[LINK IT TWO] [Phase 4]
Phase 4 clinical trial evaluating lesional changes in high-risk patients with neoatherosclerosis treated with rosuvastatin and EPA, assessed…